Background
==========

Lately, much interest has been focused on global multilocus procedures that test for overall association of sets of markers. This is appealing if the loci carry rare variants or are thought to belong to a specific gene set, such as a pathway or genes with similar functions. The kernel score statistic is a specific type of such a global covariate-adjusted multilocus association test. Depending on context, it has received different names, such as SKAT (sequence kernel association test) \[[@B1]\]. Kernel methods provide flexible semiparametric regression models of multimarker genetic influence on expected trait outcome and can conveniently be implemented within the linear mixed-model formalism \[[@B2],[@B3]\]. The kernel expresses genetic correlation between subjects. It allows us to test a whole model class by defining a prior probability in function space in a bayesian manner \[[@B4]\]. In contrast, standard regression models are limited to just 1 *a priori*stated submodel of such a class.

Until very recently, kernel methods were only applied to independent data (see Ref. \[[@B5]\] for a review). An extension to include familial dependence was made for trait prediction \[[@B6]\], but not for testing genetic influence. This changed with independent Genetic Analysis Workshop 18 (GAW18) contributions by ourselves and others (Huang et al \[[@B7]\], Chen et al \[[@B8]\], Dufresne et al \[[@B9]\], and Schifano et al \[[@B10]\]). Huang et al \[[@B7]\] applied the kernel method to trios. The other 4 contributions (including ours) use a similar kernel extension to families with different study aims. We generalize the kernel score statistic to adjust for dependency in metric trait data. We apply it to real and simulated GAW18 baseline systolic blood pressure (SBP) and contrast its performance on the sequenced panel in comparison to tag-single-nucleotide polymorphisms (SNPs) of a genome-wide association study (GWAS).

Methods
=======

Data
----

GAW18 provided blood pressure trait data from Mexican Americans participating in the San Antonio Family Heart Study or the San Antonio Family Diabetes/Gallbladder Study, and in the Type 2 Diabetes Genetic Exploration by Next-generation sequencing in Ethnic Samples (T2D-GENES) Project 2 study \[[@B11]\]. The sample is enriched for type 2 diabetes and for rare variants. Complete dense SNP allele dosage data were provided for 959 subjects from 20 large pedigrees with 22 to 86 members. Data are based on genome-wide tag-SNP genotyping of all subjects, whole-genome sequencing of 464 selected subjects, and imputation of all missing dosages for the remaining SNPs and subjects, exploiting kinship within pedigrees \[[@B11]\]. We considered only subjects with known baseline SBP, sex, and age, who were not on blood pressure medication: 706 subjects with real SBP, excluding the first listed twin of monozygotic twin pairs and 740 to 781 subjects with simulated SBP (subject numbers vary for 200 simulated study replicates as a result of inclusion criteria). We tested candidate genes on chromosome 3 only (real SBP: 5 genes selected based on previous association reports \[[@B12]\], simulated SBP: gene *MAP4*). From group discussions, we knew that *MAP4*associates with simulated SBP and that simulated trait Q1 mimics the segregation of genes within families, but otherwise represents the genetic null hypothesis.

Kernel score statistic with adjustment for random confounders
-------------------------------------------------------------

We analysed baseline SBP, which has a right-skewed distribution toward large extremes. This was amended by a priori rank-normalization (Blom transformation \[[@B13]\]) of SBP to a standard normally distributed target variable Y~i~= F^−1^((r~i~-3/8)/(n~obs~+1/4)). F^−1^denotes the standard normal distribution quantile; n~obs~the number of observed SBP values; and r~i~their respective rank. Individual traits Y~i~for i = 1, \..., n subjects were modeled to depend on fixed effects **b**of covariates **X**~*i*~ (intercept, age, sex, age × sex interaction), on random effects **c**for shared familial polygenic background, and on a semiparametric model h(**G**) of a genetic marker set **G**.

$$\left. \textsf{Y}_{\textsf{i}} \right.\sim\textbf{X}_{\textsf{i}}\textbf{b}^{\textsf{T}} + \textbf{Z}_{\textsf{i}}\textbf{c}^{\textsf{T}} + \textsf{h(}\textbf{G}\textsf{)}$$

Vectors **X**~i~and **Z**~i~represent the subject rows of respective design matrices **X**, **Z**for fixed covariate effects and random family effects. The semiparametric model h(**G**) can be written as **h**=**Ka**^T^with n × n dimensional kernel matrix **K**and multivariate normally distributed random effects estimates **a**\~*N*(0,τ**K**) \[[@B2]\]. The kernel score statistic tests for a genetic covariance component τ with null hypothesis H~0~: τ = 0. Most conveniently, it can be computed based on restricted maximum likelihood parameter estimates of the genetic null model

$$\textbf{Y} = \textbf{Xb}_{\textbf{o}}^{\textsf{T}} + \textbf{Zc}_{\textbf{o}}^{\textsf{T}} + \textbf{e},$$

which estimates only fixed covariate effects **b~o~**, random pedigree effects **c~o~**, polygenic component variance s^2^~fam~and residual variance s^2^, **e**\~*N*(0,s ^2^**I**). Extending the kernel score statistic to adjust for familial dependencies, we obtain test statistic

$$\textsf{Q} = \left( {\textbf{Y} - \textbf{Xb}_{\textbf{o}}^{\textsf{T}}} \right)^{\textsf{T}}\textbf{V}_{\textsf{o}}^{- 1}\textbf{KV}_{\textsf{o}}^{- 1}\left( {\textbf{Y} - \textbf{Xb}_{\textbf{o}}^{\textsf{T}}} \right)/\textsf{2}$$

with matrix **V**~o~= s^2^**I**+s^2^~fam~**ZZ**^T^. With fixed effects estimate **b~o~=**(**X**^T^**V**~o~^−**1**^**X**)^−**1**^**X**^T^**V**~o~^−**1**^**Y**, we rewrite test statistic (3) as quadratic form Q=**R**^T^**MR**of standard normally distributed residuals **R**= **P**~o~^1/2^**Y**with matrix **M=**(**P**~o~^1/2^**K P**~o~^1/2^)/2 and null projection matrix **P~o~=V~o~^−1^- V~o~^−1^X(X^T^V~o~^−1^X)^−1^X^T^V~o~^−1^**. The *p*values for test statistic (3) can be calculated by the Davies exact method \[[@B14]\] with the R package CompQuadForm from sample estimates Q and all eigenvalues of matrix **M**. We adjusted for polygenic familial background based on the kinship coefficient matrix Φ~kin~=**ZZ**^T^using R-packages kinship2 and coxme with R-function lmekin for genetic null model (2). We employed a linear kernel on allele dosages. This allows for additive genetic models on tested markers. The kernel matrix entry **K**~ij~=**g**~i~^T^**g**~j~for 2 subjects i, j is the scalar product of their subject-specific vectors **g**~i~, **g**~j~of allele dosages for N~SNP~SNP marker. SNPs were included for testing if their Hardy-Weinberg equilibrium test *p*values ≥10^−5^(rounding imputed dosages for this purpose only). We contrasted test performance for the same subjects on 2 SNP panels, sequence (allele dosage data) versus GWAS (allele dosage data reduced to intersection with GWAS SNPs).

Results
=======

Permutation testing demonstrated overall test validity: 50,000 permutations of subject-genotype assignment (permuting across families) yielded type I error 0.049 ± 0.0019, 0.00046 ± 0.00019 at significance level 0.05, 0.0005 for simulated SBP on all sequenced rare *MAP4*SNPs. Simulated trait Q1 was used to test the quality of polygenic adjustment. We analyzed Q1 analogously to SBP on gene *MAP4*and obtained *p*values ≤0.05 with rate 0.02 (all SNPs, and SNPs with minor allele frequency (MAF) \>5%), rate 0.05 (for MAF 1% to 5%), and 0.06 (for MAF \<1%). This is within 95% tolerance limits (0.02, 0.08) for true value 0.05 on 200 replicates.

For simulated SBP, associated gene *MAP4*was detected with 100%, 62.5%, and 21.5% power at significance levels 0.05, 10^−4^, and 10^−8^ on 200 study replicates when subjecting the *MAP4*sequence to the global test. Power diminished by only 0% to 2.5% when using the GWAS panel instead, or only MAF \>5% SNPs. Figure [1](#F1){ref-type="fig"} displays power to detect *MAP4*association based on MAF ≤5% SNPs. We varied the significance level to compare test performance on the sequence (filled circles) with the considerably sparser GWAS panel (open circles). Sequenced data are powerful and outperform GWAS data particularly for very rare SNPs (MAF \<1%) where GWAS had no power (Figure [1](#F1){ref-type="fig"}, *right*). GWAS outperformed sequence data on SNPs with MAF 1% to 5% (Figure [1](#F1){ref-type="fig"}, *left*) with just 11 tag-SNPs compared to 105 sequenced SNPs.

![**Simulated SBP associates with gene *MAP4*** . Power estimates of the kernel score statistic with 95% confidence limits over 200 simulated study replicates as function of the significance level. The association between rank-normalized simulated systolic blood pressure and *MAP4*was tested, adjusting for age, sex, age × sex interaction, and familial polygenic background. Polymorphic SNP numbers vary between study replicates for very rare SNPs with MAF \<1% (range in legend, *right panel*), but not for MAF 1% to 5% (*left panel*).](1753-6561-8-S1-S41-1){#F1}

Table [1](#T1){ref-type="table"} displays association of real SBP with the 5 selected candidate genes on chromosome 3. *P*values do not withstand Bonferroni correction. Note, however, the difference between sequence (*p*= 0.150) and GWAS (*p*= 0.031) for *MECOM*SNPs with MAF 1% to 5%. For *AGTR1*, sequence data tend to reduce *p*values compared to GWAS, as well as for *SLC4A7*on rare variants. We partitioned the large *MECOM, ULK4*sequences based on number of SNPs, as we expect that power improves by changing from a situation where we test over many more SNPs compared to number of subjects (full gene) to a situation with fewer SNPs than subjects (gene parts).

###### 

Real SBP and candidate genes on chromosome 3

  Gene       SNP panel   Kernel score statistic (linear kernel on allele dosage data)                                                    
  ---------- ----------- -------------------------------------------------------------- ------- ------ ------- ------ ------------ ----- -------
  *MECOM*    GWAS        212                                                            0.840   176    0.873   33     **0.031**    3     0.333
             Sequence    2530                                                           0.826   1222   0.864   621    0.150        687   0.289
             Sequence    \- 4 consecutive windows                                                                                        
                         633                                                            0.976   364    0.977   93     0.482        176   0.890
                         633                                                            0.557   229    0.709   198    **0.0071**   206   0.197
                         632                                                            0.251   340    0.252   161    0.371        131   0.137
                         632                                                            0.919   289    0.933   169    0.467        174   0.216
                                                                                                                                         
  *ULK4*     GWAS        188                                                            0.770   146    0.783   40     0.258        2     0.430
             Sequence    3333                                                           0.510   1569   0.518   1007   0.302        757   0.459
             Sequence    \- 5 consecutive windows                                                                                        
                         667                                                            0.661   314    0.648   177    0.499        176   0.301
                         667                                                            0.791   373    0.812   125    0.171        169   0.409
                         667                                                            0.738   296    0.813   208    0.108        163   0.446
                         666                                                            0.132   261    0.124   256    0.364        149   0.432
                         666                                                            0.141   325    0.132   241    0.540        100   0.830
                                                                                                                                         
  *PPARG*    GWAS        148                                                            0.693   90     0.664   32     0.880        26    0.998
             Sequence    583                                                            0.841   269    0.803   121    0.989        193   0.990
                                                                                                                                         
  *AGTR1*    GWAS        39                                                             0.277   27     0.296   11     0.097        1     0.482
             Sequence    497                                                            0.081   174    0.091   172    0.100        151   0.223
                                                                                                                                         
  *SLC4A7*   GWAS        27                                                             0.688   13     0.789   10     0.134        4     0.208
             Sequence    375                                                            0.776   149    0.864   82     0.099        144   0.158

Kernel score test over N~SNP~SNP marker for rank-normalized systolic blood pressure, adjusted for age, sex, age × sex interaction, and familial background (*p*≤0.05 in bold).

Conclusions
===========

The kernel score statistic is a global covariance component test. *P*values for genes are dominated by their common SNPs (see Table [1](#T1){ref-type="table"}: all SNPs vs. MAF \>5%). Thus, common and rare SNP sets should be tested separately. The kernel method offers a simple and flexible way to perform multimarker analysis and genetic interaction analyses by means of the kernel choice. It improves power compared to single-marker tests by exploiting SNP correlation \[[@B10]\], and if jointly tested SNP sets tag multiple independent associated loci. The test statistic by Liu et al and Tzeng et al \[[@B2],[@B3]\] had 17% power at the 0.01 level for independent subjects to find *MAP4*association with simulated SBP in 200 replicates. Our extension to families increased this to 98.5% power, used 84% more subjects with twice as many polymorphic SNPs (sequence), without type I error inflation. Ignoring familial dependency would inflate type I error to 16%, 6% at nominal 0.05, 0.01 levels (applying the independent subjects test statistic \[[@B2],[@B3]\] to families for *MAP4*on polygenic trait Q1). We found that sequencing can improve test power appreciably, particularly for MAF \<1% variants (Figure [1](#F1){ref-type="fig"}, *right*). For more frequent SNPs, the comparison was not decisive and tag-SNPs proved to be strong competitors. With sequencing, even a single, large gene may provide more SNP variants than available study subjects. The kernel score test remains valid because of the Bayesian nature of the underlying nonparametric genetic model \[[@B4]\]. However, one might expect power loss. The kernel score statistic may be susceptible to random confounders. For example, simplistic adjustment of familial and common cultural effects by a familial random intercepts model (instead of the polygenic model) yields valid permutation test results, but shows up as inflated type I errors on simulated polygenic trait Q1 (*p*≤0.05 on 10% of 200 study replicates for all *MAP4*SNPs, inflation increases with decreasing MAF). This, in turn, would yield similar but overly optimistic estimates for Figure [1](#F1){ref-type="fig"} and Table [1](#T1){ref-type="table"}. With such a liberal test, *AGTR1 p*values in Table [1](#T1){ref-type="table"} would all drop below 0.05 for all sequence SNP sets. We would like to emphasize that other random confounder effects, such as different trait variability between study subgroups, can be adjusted in exact analogy to the familial polygenic background adjustment.
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